Pro-inflammatory genetic profiles in subjects with peripheral arterial occlusive disease and critical limb ischemia

Journal of Internal Medicine

Volumn 262, Issue 1, 2007, Pages 124-130

  Flex, A ^a   Gaetani, E ^a   Angelini, F ^a   Sabusco, A ^a   Chilla C ^a   Straface, G ^a   Biscetti, F ^a   Pola, P ^a   Castellot Jr , J J ^b   Pola, R ^a,b,c  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c OASI RESEARCH INSTITUTE IRCCS   (Italy)

Author keywords

Critical limb ischemia; Gene polymorphism; Genetic profile; Inflammation; Peripheral arterial occlusive disease

Indexed keywords

C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GELATINASE B; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; MACROPHAGE MIGRATION INHIBITION FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; STROMELYSIN;

AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC RISK; GENOTYPE; HUMAN; LIMB ISCHEMIA; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS;

AGED; AGED, 80 AND OVER; ARTERIAL OCCLUSIVE DISEASES; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFLAMMATION MEDIATORS; ISCHEMIA; LEG; MALE; PERIPHERAL VASCULAR DISEASES; POLYMORPHISM, SINGLE NUCLEOTIDE; SEVERITY OF ILLNESS INDEX;

EID: 34347204142     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2007.01791.x     Document Type: Article

References (32)

1. Criqui MH, Langer RD, Fronek A et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992 326 : 381 6.
2. Violi F, Criqui M, Longoni A, Castiglioni C, Relation between risk factors and cardiovascular complications in patients with peripheral arterial disease - results from the A.D.E.P. study. Atherosclerosis 1996 120 : 25 35.
3. Cesari M, Penninx BW, Newman AB et al. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation 2003 108 : 2317 22.
4. Burger-Kentischer A, Goebel H, Seiler R, Fraedrich G et al. Expression of macrophage migration inhibitory factor in different stages of human atherosclerosis. Circulation 2002 105 : 1561 6.
5. Jibiki T, Terai M, Shima M et al. Monocyte chemoattractant protein 1 gene regulatory region polymorphism and serum levels of monocyte chemoattractant protein 1 in Japanese patients with Kawasaki disease. Arthritis Rheum 2001 44 : 2211 2.
6. Fishman D, Faulds G, Jeffery R et al. The effect of novel polymorphism in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic onset juvenile chronic arthritis. J Clin Invest 1998 102 : 1369 76.
7. De Benedetti F, Meazza C, Vivarelli M, British Paediatric Rheumatology Study Group. Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2003 : 48 1398 407.
8. Zee RY, Ridker PM. Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis. Atherosclerosis 2002 162 : 217 9.
9. Staunton DE, Marlin SD, Stratowa C, Dustin ML, Springer TA. Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell 1988 52 : 925 33.
10. Yoshida M, Takano Y, Sasaoka T, Izumi T, Kimura A. E-selectin polymorphism associated with myocardial infarction causes enhanced leukocyte-endothelial interactions under flow conditions. Arterioscler Thromb Vasc Biol 2003 23 : 783 8.
11. Kim JS. Cytokines and adhesion molecules in stroke and related diseases. J Neurol Sci 1996 137 : 69 78.
12. Frijns CJ, Kappelle LJ. Inflammatory cell adhesion molecules in ischemic cerebrovascular disease. Stroke 2002 33 : 2115 22.
13. Ishikawa M, Cooper D, Russell J et al. Molecular determinants of the prothrombogenic and inflammatory phenotype assumed by the postischemic cerebral microcirculation. Stroke 2003 34 : 1777 82.
14. Garlichs CD, Kozina S, Fateh-Moghadam S et al. Upregulation of CD40-CD40 ligand (CD154) in patients with acute cerebral ischemia. Stroke 2003 34 : 1412 8.
15. Okamoto Y, Satomura K, Ohsuzu F, Nakamura H, Takeuchi K, Yoshioka M. Expression of matrix metalloproteinase 3 in experimental atherosclerotic plaques. J Atheroscler Thromb 2001 8 : 50 4.
16. Pola R, Flex A, Gaetani E, Flore R, Serricchio M, Pola P. Synergistic effect of -174 G/C polymorphism of the interleukin-6 gene promoter and 469 E/K polymorphism of the intercellular adhesion molecule-1 gene in Italian patients with history of ischemic stroke. Stroke 2003 34 : 881 5.
17. Flex A, Gaetani E, Papaleo P et al. Proinflammatory genetic profiles in subjects with history of ischemic stroke. Stroke 2004 35 : 2270 5.
18. Rutherford RB, Flanigan DP, Gupta SK the Ad Hoc Committee on Reporting Standards SVS/ISCVS. Suggested standards for reports dealing with lower extremity ischaemia. J Vasc Surg 1986 4 : 80 94.
19. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 2000 31 : S1 296.
20. Cao H, Hegele RA. Human C-reactive protein (CRP) 1059G/C polymorphism. J Hum Genet 2000 45 : 100 1.
21. Fernandez-Real JM, Vayreda M, Richart C et al. Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J Clin Endocrinol Metab 2001 86 : 1154 9.
22. Donn RP, Shelley E, Ollier WE, British Paediatric Rheumatology Study Group. A novel 5′-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2001 44 : 1782 5.
23. Nejentsev S, Laine AP, Simell O, Ilonen J. Intercellular adhesion molecule-1 (ICAM-1) K469E polymorphism: no association with type 1 diabetes among Finns. Tissue Antigens 2000 55 : 568 70.
24. Rauchhaus M, Gross M, Schulz S, Francis DP et al. The E-selectin SER128ARG gene polymorphism and restenosis after successful coronary angioplasty. Int J Cardiol 2002 83 : 249 57.
25. Aguilar F, Gonzalez-Escribano MF, Sanchez-Roman J, Nunez-Roldan A. MCP-1 promoter polymorphism in Spanish patients with systemic lupus erythematosus. Tissue Antigens 2001 58 : 335 8.
26. Lee YH, Kim HJ, Rho YH, Choi SJ, Ji JD, Song GG. Functional polymorphisms in matrix metalloproteinase-1 and monocyte chemoattractant protein-1 and rheumatoid arthritis. Scand J Rheumatol 2003 32 : 235 9.
27. Gnasso A, Motti C, Irace C et al. Genetic variation in human stromelysin gene promoter and common carotid geometry in healthy male subjects. Arterioscler Thromb Vasc Biol 2000 20 : 1600 5.
28. Jones GT, Phillips VL, Harris EL, Rossaak JI, van Rij AM. Functional matrix metalloproteinase-9 polymorphism (C-1562T) associated with abdominal aortic aneurysm. J Vasc Surg 2003 38 : 1363 7.
29. Machado JC, Figueiredo C, Canedo P et al. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 2003 125 : 364 71.
30. Weyand CM, Klimiuk PA, Goronzy JJ. Heterogeneity of rheumatoid arthritis: from phenotypes to genotypes. Springer Semin Immunopathol 1998 20 : 5 22.
31. Yamada R, Tanaka T, Unoki M et al. Association between a single-nucleotide polymorphism in the promoter of the human interleukin-3 gene and rheumatoid arthritis in Japanese patients, and maximum-likelihood estimation of combinatorial effect that two genetic loci have on susceptibility to the disease. Am J Hum Genet 2001 68 : 674 85.
32. Zhu Y, Spitz MR, Lei L, Mills GB, Wu X. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res 2001 61 : 7825 9.